Navigation Links
Reportlinker Adds Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Date:9/14/2010

NEW YORK Sept. 14 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

http://www.reportlinker.com/p0208577/Global-Coronary-Stents-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016.html

Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

SummaryGlobalData's medical equipment report, "Global Coronary Stents Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global coronary stents market, a key segment within cardiovascular devices. The report provides market landscape, competitive landscape and market trends information the coronary stents market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Bare Metal Stents (BMS) and Drug Eluting Stents (DES).

- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the coronary stents market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Cordis, Boston Scientific Corporation, Medtronic and Abbott.

Reasons to buy- Develop business strategies by understanding the trends and developments that are driving the coronary stents market globally.

- Design and develop your product development, marketing and sales strategies.

- Exploit M&A opportunities by identifying market players with the most innovative pipeline.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next being thing in the coronary stents market landscape? – Identify, understand and capitalize.

- Make more informed business decisions from the insightful and in-depth analysis of the global coronary stents market and the factors shaping it.

1 Table of contents 3

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction: Coronary Stents 9

2.1 GlobalData Report Guidance 9

3 Disease Overview: Coronary Heart Disease (CHD) 10

3.1 Pathophysiology 10

3.2 Signs and Symptoms 10

3.3 Risk Factor 11

3.3.1 Major Risk Factors that can't be Altered 11

3.3.2 Major Risk Factors that can be Altered 11

3.3.3 Other Risk Factors 11

3.4 Diagnosis 12

3.4.1 Electrocardiogram (ECG or EKG): 12

3.4.2 Exercise thallium test: 12

3.4.3 Echocardiography: 12

3.4.4 Coronary angiography: 12

3.4.5 Positron Emission Tomography (PET scanning): 12

3.5 Treatment 12

3.5.1 Coronary Heart Disease Epidemiology 12

3.5.2 Treatment modalities for CHD 15

4 Global Coronary Stents Market Characterization 16

4.1 Global Coronary Stents Market, Revenues ($bn), Historic, 2002 – 2009 16

4.2 Global Coronary Stents Market, Revenues ($bn), Forecast, 2009 – 2016 17

4.3 Global Coronary Stents, Market Dynamics 18

4.3.1 Coronary Stents: Market Drivers 18

4.3.2 Coronary Stents: Market Restraints 20

5 Global Coronary Stents Market: Segment Analysis 22

5.1 Bare Metal Stents, Global, Revenue ($bn), Historic, 2002– 2009 22

5.1.1 Bare Metal Stents, Global, Revenue ($bn), Forecast, 2009– 2016 23

5.2 Global Bare Metal Stents: Market Dynamics 24

5.2.1 Bare Metal Stents: Market Drivers 24

5.2.2 Bare Metal Stents: Market Restraints 24

5.2.3 Drug Eluting Stents, Global, Revenue ($bn), Historic, 2002– 2009 25

5.2.4 Drug Eluting Stents, Global, Revenue ($bn), Forecast, 2009– 2016. 26

5.3 Global Drug Eluting Stents:Market Dynamics 26

5.3.1 Drug Eluting Stents: Market Drivers 26

5.3.2 Drug Eluting Stents: Market Restraints 27

6 The Global Coronary Stents Market: Cross Country Analysis and Forecasts 28

6.1 Revenue and Revenue Forecast, By Country 29

6.1.1 US Coronary Stents market, Revenue ($ m), Historic, 2002-2009 29

6.1.2 US Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 30

6.1.3 Canada Coronary Stents market, Revenue ($ m), Historic, 2002-2009 31

6.1.4 Canada, Coronary Stents market, Revenue ($ m), Forecast, 2002-2009 32

6.1.5 UK Coronary Stents market, Revenue ($ m), Historic, 2002-2009 33

6.1.6 UK Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 34

6.1.7 Italy, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 35

6.1.8 Germany, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 37

6.1.9 Germany, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 38

6.1.10 France, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 39

6.1.11 France, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 40

6.1.12 Spain, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 41

6.1.13 Spain, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 42

6.1.14 Japan, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 43

6.1.15 Japan, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 44

6.1.16 China, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 45

6.1.17 China, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 46

6.1.18 India, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 47

6.1.19 India, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 48

6.1.20 Brazil, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 49

6.1.21 Brazil, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 50

6.1.22 Australia, Coronary Stents market, Revenue ($ m), Historic, 2002-2009 51

6.1.23 Australia, Coronary Stents market, Revenue ($ m), Forecast, 2009-2016 52

7 Global Coronary Stents Market: Strategic Competitive Assesment 53

7.1 Boston Scientific Corporation 55

7.1.1 Overview: 55

7.2 Cordis Corporation 56

7.2.1 Overview 56

7.3 Abbott Laboratories 57

7.3.1 Overview 57

7.4 Medtronic, Inc. 58

7.4.1 Overview 58

8 Global coronary Stents Market, Key Marketed products 60

8.1 Key Coronary Stents in the Market 60

8.1.1 CYPHER sirolimus-eluting coronary stents (JNJ Cordis) 60

8.1.2 PROMUS (Boston Scientific) 63

8.1.3 ENDEAVOR (Medtronic) 66

8.1.4 TAXUS Express2 (Boston Scientific) 69

8.1.5 TAXUS Liberte (Boston Scientific) 71

8.1.6 TriMaxx Coronary Stent (Abbott) 73

8.1.7 MULTI-LINK FRONTIER Coronary Bifurcation Stent System (Abbott) 73

9 Global Coronary Stents Market: Strategic Pipeline Assessment 74

9.1 Pipeline Technology Assessment 74

9.1.1 Pipeline Technology Assessment for Coronary Stents by Development Stage, Global 74

9.1.2 Emerging Technologies in the Coronary Stent Market 77

9.2 Profiles of Promising Products Under Clinical Development: 78

9.2.1 BioMatrix Drug Eluting Stent (Biosensors) 78

9.2.2 NEVO Sirolimus-eluting Coronary Stent (Cordis) 80

9.2.3 PROTEX Coronary Stent System (Nexeon MedSystems) 83

9.2.4 Valecor Platinum Coronary Stent System (CorNova) 83

9.2.5 GTX Coronary Stent System (Cook Medical) 84

9.2.6 JST Drug-Eluting Stent (Japan Stent Technology) 85

9.2.7 ProGenic Pimecrolimus-eluting Coronary Stent System (BIOTRONIK SE & Co. KG) 85

9.2.8 MAHOROBA (KANEKA CORPORATION) 86

9.2.9 ProLink LP (Vascular Concepts Limited) 87

9.2.10 ChromoFlex Coronary Stent (DISA Vascular) 88

9.2.11 Next generation everolimus-based stent (Boston Scientific) 89

9.2.12 ProNova Sirolimus Eluting Stent (Vascular Concepts Limited) 89

9.2.13 Coroflex DEBlue (B. Braun Melsungen AG) 90

9.2.14 Endeavor Resolute (Medtronic) 92

9.2.15 XIENCE NANO (Abbott Vascular) 94

9.2.16 TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System (Boston Scientific) 94

9.2.17 CYPHER Max (4.0) (RX) (Cordis Corporation) 97

9.3 Coronary Stents:List of Pipeline Products 97

10 Global Coronary Stents Market: Key Companies with Products in Clinical Development 104

10.1.1 Biosensors International Group, Ltd. 104

10.1.2 Cook Medical Incorporated 104

10.1.3 OrbusNeich 105

10.1.4 Vascular Concepts Limited 106

10.1.5 CorNova, Inc. 106

10.1.6 Nexeon MedSystems, Inc. 107

11 Global Coronary Stents Market: Strategic Deals Analysis 108

11.1 Key Acquisitions 108

11.1.1 Medtronic Completes Acquisition Of Invatec And Affiliated Companies 109

11.1.2 Boston Scientific Acquires Labcoat 109

11.1.3 Bayer MaterialScience Completes Acquisition Of PolyBioMed From Lombard Medical Technologies 109

12 Appendix 111

12.1 Definitions 111

12.1.1 Coronary Stents 111

12.2 Acronyms 111

12.3 Research Methodology 112

12.4 Secondary Research 113

12.5 Primary Research 113

12.6 Models 114

12.7 Forecasts 114

12.8 Expert Panels 114

12.9 GlobalData Consulting 115

12.10 Contact Us 115

12.11 Disclaimer 115

1.1 List of TablesTable 1: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009 16

Table 2: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016 17

Table 3: Bare Metal Stents, Global, Revenue ($bn), 2002– 2009 22

Table 4: Bare Metal Stents, Global, Revenue ($bn), 2009–2016 23

Table 5: Drug Eluting Stents Market, Global, Revenue ($bn), 2002– 2009 25

Table 6: Drug Eluting Stents, Global, Revenue ($bn), 2009– 2016 26

Table 7: Coronary Stents Market, Cross Country Analysis, Revenue ($m) and CAGR (%), 2002-2016 28

Table 8: Coronary Stents Market, US, Revenue ($ m), 2002-2009 29

Table 9: Coronary Stents Market, US, Revenue ($ m), 2009-2016 30

Table 10:Coronary Stents Market, Canada, Revenue ($ m), 2002-2009 31

Table 11:Coronary Stents Market, Canada, Revenue ($ m), 2009-2016 32

Table 12: Coronary Stents Market, UK, Revenue ($ m), 2002-2009 33

Table 13: Coronary Stents Market, UK, Revenue ($ m), 2009-2016 34

Table 14: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009 35

Table 15: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016 36

Table 16: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009 37

Table 17: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016 38

Table 18: Coronary Stents Market, France, Revenue ($ m), 2002-2009 39

Table 19: Coronary Stents Market, France, Revenue ($ m), 2009-2016 40

Table 20: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009 41

Table 21: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016 42

Table 22: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009 43

Table 23: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016 44

Table 24: Coronary Stents Market,China, Revenue ($ m), 2002-2009 45

Table 25: Coronary Stents Market,China, Revenue ($ m), 2009-2016 46

Table 26: Coronary Stents Market, India, Revenue ($ m), 2002-2009 47

Table 27: Coronary Stents Market, India, Revenue ($ m), 2009-2016 48

Table 28: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009 49

Table 29: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016 50

Table 30: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009 51

Table 31: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016 52

Table 32: Drug Eluting Stents Market , Global, Company Shares Revenue ($m), 2009 53

Table 33: Bare Metal Stents Market, Global, Company Shares Revenue ($m), 2009 54

Table 34: Boston Scientific Corporation, Coronary Stents, Pipeline Products 56

Table 35: Cordis, Coronary Stents, Pipeline Products 57

Table 36: Abbott Coronary Stents Pipeline Products 58

Table 37: Medtronic Coronary Stents Pipeline Products 59

Table 38: Current Drug-Eluting Stents Approved for Use in the US 60

Table 39: CYPHER Coronary Stent 60

Table 40: CYPHER (SIRIUS Pivotal Trial) 61

Table 41: CYPHER (RAVEL Supporting Trial) 62

Table 42: PROMUS Coronary Stent 63

Table 43: PROMUS (SPIRIT III Trial)) 64

Table 44: ENDEAVOR Coronary Stent 66

Table 45: ENDEAVOR (ENDEAVOR III Trial)) 66

Table 46: ENDEAVOR (ENDEAVOR IV Trial)) 68

Table 47: TAXUS Express2 (TAXUS IV Trial)) 70

Table 48: TAXUS Liberte (ATLAS Trial)) 72

Table 49: Biomatrix III (LEADER Trial) 78

Table 50: Biomatrix (STEALTH) 80

Table 51: NEVO Sirolimus-eluting coronary stent (RES-ELUTION II) 81

Table 52: NEVO Sirolimus-eluting coronary stent (RES-ELUTION I): Pivotal trial 83

Table 53: GTX Coronary Stent System 84

Table 54: ProGenic Pimecrolimus-eluting Coronary Stent System 85

Table 55: MAHOROBA 87

Table 56: ProLink LP 88

Table 57: ChromoFlex Coronary Stent 89

Table 58: ProNova Sirolimus Eluting Stent 90

Table 59: Coroflex DEBlue (PEPCADIIIsub) 91

Table 60: ENDEAVOR Resolute 92

Table 61: TAXUS Petal Bifurcation Paclitaxel-Eluting Stent System 95

Table 62: Coronary Stents : Pipeline Summary 97

Table 63: Biosensors International Group Pipeline Products 104

Table 64: Cook Medical Pipeline Products 105

Table 65: OrbusNeich Pipeline Products 105

Table 66: Vascular Concepts Limited Pipeline Products 106

Table 67: CorNova, Inc Pipeline 107

Table 68: Nexeon MedSystems, Inc Pipeline Products 107

Table 69: Coronary Stents: Key Acquisitions 108

1.2 List of FiguresFigure 1: Signs and Symptoms of Coronary Heart Disease 10

Figure 2: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, US, 2009 12

Figure 3: Treatment Flow Model, Coronary Stents for Treatment of Coronary Heart Disease, Europe, 2009 13

Figure 4: Treatment Modalities for Coronary Heart Disease, 2009 15

Figure 5: Coronary Stents Market, Global, Revenue ($bn), 2002 – 2009 16

Figure 6: Coronary Stents Market, Global, Revenue ($bn), 2009 – 2016 17

Figure 7: Drivers and Restraints in the Coronary Stents Market 18

Figure 8: US, Breakdown of Deaths from Cardiovascular Diseases, %,2006 18

Figure 9 Bare Metal Stents Market, Global, Revenue ($bn), 2002– 2009 22

Figure 10: Bare Metal Stents Market, Global, Revenue ($bn), 2009–2016 23

Figure 11: Drug Eluting Stents Market, Global, Revenue ($bn), 2002–2009 25

Figure 12: Drug Eluting Stents Market, Global, Revenue ($bn), 2009– 2016 26

Figure 13: Coronary Stents Market, Cross Country Analysis, Global, Revenue and growth Comparison 2002-2016 28

Figure 14: Coronary Stents Market, US, Revenue ($ m), 2002-2009 29

Figure 15: Coronary Stents Market, US, Revenue ($ m), 2009-2016 30

Figure 16: Coronary Stents Market, Canada, Revenue ($ m), 2002-2009 31

Figure 17: Coronary Stents Market, Canada, Revenue ($ m), 2009-2016 32

Figure 18: Coronary Stents Market, UK, Revenue ($ m), 2002-2009 33

Figure 19: Coronary Stents Market, UK, Revenue ($ m), 2009-2016 34

Figure 20: Coronary Stents Market, Italy, Revenue ($ m), 2002-2009 35

Figure 21: Coronary Stents Market, Italy, Revenue ($ m), 2009-2016 36

Figure 22: Coronary Stents Market, Germany, Revenue ($ m), 2002-2009 37

Figure 23: Coronary Stents Market, Germany, Revenue ($ m), 2009-2016 38

Figure 24: Coronary Stents Market, France, Revenue ($ m), 2002-2009 39

Figure 25: Coronary Stents Market, France, Revenue ($ m), 2009-2016 40

Figure 26: Coronary Stents Market, Spain, Revenue ($ m), 2002-2009 41

Figure 27: Coronary Stents Market, Spain, Revenue ($ m), 2009-2016 42

Figure 28: Coronary Stents Market, Japan, Revenue ($ m), 2002-2009 43

Figure 29: Coronary Stents Market, Japan, Revenue ($ m), 2009-2016 44

Figure 30: Coronary Stents Market,China, Revenue ($ m), 2002-2009 45

Figure 31: Coronary Stents Market, China, Revenue ($ m), 2009-2016 46

Figure 32: Coronary Stents Market, India, Revenue ($ m), 2002-2009 47

Figure 33: Coronary Stents Market, India, Revenue ($ m), 2009-2016 48

Figure 34: Coronary Stents Market, Brazil, Revenue ($ m), 2002-2009 49

Figure 35: Coronary Stents Market, Brazil, Revenue ($ m), 2009-2016 50

Figure 36: Coronary Stents Market, Australia, Revenue ($ m), 2002-2009 51

Figure 37: Coronary Stents Market, Australia, Revenue ($ m), 2009-2016 52

Figure 38: Drug Eluting Stents Market, Global, Company Share (% of Revenue), 2009 53

Figure 39: Bare Metal Stents Market, Global, Company Shares (% Revenue), 2009 54

Figure 40: Pipeline Technology Assessment for Coronary Stents by Development Stage, Global 74

Figure 41: Pipeline Technology Assessment for Drug Eluting and Bare Metal Stents By Development Stage, Global 75

Figure 42: Pipeline Technology Assessment for Drug Eluting Stents by Unmet Need, Global 76

Figure 43: Pipeline Technology Assessment for Bare Metal Stents by Unmet Need, Global 77

Figure 44: Key Acquisitions in 2009-2010 108

Figure 45: GlobalData Methodology 113

Companies mentioned Boston Scientific Corporation

Cordis Corporation

Abbott Laboratories

Medtronic, Inc

To order this report:Medical Devices Industry: Global Coronary Stents Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

Medical Devices Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!CONTACT:Nicolas BombourgReportlinkerEmail: nbo@reportlinker.comUS: (805)652-2626Intl: +1 805-652-2626
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
(Date:12/8/2016)... -- Mederi Therapeutics Inc . hat die behördliche Zulassung durch die ... Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the ... at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it had joined the Pharmaceutical ... a non-profit organization to unite pharmaceutical and healthcare companies that share a vision ...
(Date:12/8/2016)... ... 2016 , ... Healthcare is in flux. The GOP wants ... mass media launching of story movements to highlight what's most unfair about healthcare. ... such a movement can generate the network power to improve healthcare policies in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, ... and around the greater Phoenix metropolitan region, is announcing a charity event to ... of the Homeless Youth Connection is to promote community awareness of the ongoing ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is ... by smoothing and tightening the skin of the face to create more youthful ... aging with very little downtime, Silhouette Instalift is a novel, minimally invasive facial ...
Breaking Medicine News(10 mins):